Search Results - "Yamasaki, Souichirou"

Refine Results
  1. 1

    Expressions of angiogenic factors in pancreatic ductal carcinoma: A correlative study with clinicopathologic parameters and patient survival by KUWAHARA, Kenichi, SASAKI, Tamito, KUWADA, Yukio, MURAKAMI, Masateru, YAMASAKI, Souichirou, CHAYAMA, Kazuaki

    Published in Pancreas (01-05-2003)
    “…It has been reported that angiogenic factors play an important role in proliferation and metastasis in various cancers.AIMTo investigate the expression of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Irsogladine malate up-regulates gap junctional intercellular communication between pancreatic cancer cells via PKA pathway by KAWASAKI, Yousuke, TSUCHIDA, Akira, SASAKI, Tamito, YAMASAKI, Souichirou, KUWADA, Yukio, MURAKAMI, Masateru, CHAYAMA, Kazuaki

    Published in Pancreas (01-11-2002)
    “…Gap junctions (GJs) are intercellular channels that aid communication between coupling cells and may play a critical role in cell differentiation and growth…”
    Get full text
    Journal Article
  4. 4

    Preoperative diagnosis of intraductal papillary‐mucinous tumors of the pancreas with attention to telomerase activity by Inoue, Hiroki, Tsuchida, Akira, Kawasaki, Yousuke, Fujimoto, Yoshifumi, Yamasaki, Souichirou, Kajiyama, Goro

    Published in Cancer (01-01-2001)
    “…BACKGROUND It has been reported that, in patients with intraductal papillary‐mucinous tumor (IPMT) of the pancreas, it is difficult to distinguish adenoma from…”
    Get full text
    Journal Article
  5. 5

    Induction of apoptosis by ionizing radiation and CI-1033 in HuCCT-1 cells by Murakami, Masateru, Sasaki, Tamito, Yamasaki, Souichirou, Kuwahara, Kenichi, Miyata, Hideki, Chayama, Kazuaki

    “…CI-1033 is a quinazoline-based HER family tyrosine kinase inhibitor that is currently being evaluated as a potential anticancer agent. The present study…”
    Get full text
    Journal Article
  6. 6

    Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma by Murakami, Masateru, Sasaki, Tamito, Miyata, Hideki, Yamasaki, Souichirou, Kuwahara, Kenichi, Chayama, Kazuaki

    Published in Oncology reports (01-06-2004)
    “…Alteration of the Fas receptor (Fas)-/ligand (FasL) system including their soluble forms (sFas and sFasL) is thought to be one of the mechanisms preventing the…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites by Kuwahara, Kenichi, Sasaki, Tamito, Kobayashi, Kensou, Noma, Bunjirou, Serikawa, Masahiro, Iiboshi, Tomohiro, Miyata, Hideki, Kuwada, Yukio, Murakami, Masateru, Yamasaki, Souichirou, Kariya, Kenji, Morinaka, Kenji, Chayama, Kazuaki

    Published in Oncology reports (01-01-2004)
    “…It has been reported that vascular endothelial growth factor (VEGF) is a potent angiogenic factor that also has the ability to increase vascular permeability…”
    Get more information
    Journal Article
  13. 13

    Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma by Murakami, Masateru, Sasaki, Tamito, Kuwada, Yukio, Yamasaki, Souichirou, Kuwahara, Kenichi, Chayama, Kazuaki

    Published in Oncology reports (01-09-2003)
    “…For cases of inoperable bile duct carcinoma, we perform intraluminal irradiation using an 192iridium wire following endoprostheses implantation. However, the…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20